These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 11362145)

  • 1. Aberrant alpha-interferon removed.
    AIDS Patient Care; 1994 Jun; 8(3):167. PubMed ID: 11362145
    [No Abstract]   [Full Text] [Related]  

  • 2. New roles for interferon-alpha?
    Dudjak LA
    Am J Nurs; 1992 Feb; 92(2):16. PubMed ID: 1739108
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon ineffective for AIDS.
    Am Pharm; 1992 Aug; NS32(8):14. PubMed ID: 1524014
    [No Abstract]   [Full Text] [Related]  

  • 4. [New data on acid-labile alpha-interferon].
    Shcheglovitova ON
    Vopr Virusol; 1999; 44(2):52-4. PubMed ID: 10358896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of enhanced interferon alpha levels in sera of HIV-infected and AIDS patients receiving combined antiretroviral therapy.
    Piasecki E; Knysz B; Gasiorowski J; Gładysz A
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):37-44. PubMed ID: 11729827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose interferon-alpha and HIV infection.
    Lancet; 1992 May; 339(8801):1106. PubMed ID: 1349115
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon not recommended for treatment of HIV infections.
    J Pract Nurs; 1992 Jun; 42(2):20. PubMed ID: 1602415
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interesting immunotherapy approach. An interferon as preload therapy].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():83. PubMed ID: 12043092
    [No Abstract]   [Full Text] [Related]  

  • 9. Dendritic and natural killer cell subsets associated with stable or declining CD4+ cell counts in treated HIV-1-infected children.
    Azzoni L; Rutstein RM; Chehimi J; Farabaugh MA; Nowmos A; Montaner LJ
    J Infect Dis; 2005 May; 191(9):1451-9. PubMed ID: 15809903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: successful treatment with interferon-alpha.
    Ueno T; Mitsuishi T; Kimura Y; Kato T; Hasegawa H; Katano H; Sata T; Kurane S; Kawana S
    Eur J Dermatol; 2007; 17(6):539-40. PubMed ID: 17951139
    [No Abstract]   [Full Text] [Related]  

  • 11. Opportunities "opening up" for gene therapy.
    Vanchieri C
    J Natl Cancer Inst; 1993 Jan; 85(2):90-1. PubMed ID: 8418310
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interferon status of healthy full-term neonates and their mothers].
    Koroleva LI; Evsiukova II; Sel'kov SA; Anikin VB
    Fiziol Cheloveka; 2003; 29(5):156-8. PubMed ID: 14611100
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
    Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
    Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose interferon-alpha treatment for feline immunodeficiency virus infection.
    Pedretti E; Passeri B; Amadori M; Isola P; Di Pede P; Telera A; Vescovini R; Quintavalla F; Pistello M
    Vet Immunol Immunopathol; 2006 Feb; 109(3-4):245-54. PubMed ID: 16169599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELISA measurement of interferons.
    Garrison TL; Hung F; Izotova L; Schwartz B; Lavoie T; Lee-Own FV
    Biotechniques; 2002 Oct; Suppl():98-100. PubMed ID: 12395933
    [No Abstract]   [Full Text] [Related]  

  • 16. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.
    Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G
    Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort.
    Diop G; Hirtzig T; Do H; Coulonges C; Vasilescu A; Labib T; Spadoni JL; Therwath A; Lathrop M; Matsuda F; Zagury JF
    Biomed Pharmacother; 2006 Nov; 60(9):569-77. PubMed ID: 17027223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free interferon-alpha/beta receptors in the circulation of patients with adenocarcinoma.
    Ambrus JL; Dembinski W; Ambrus JL; Sykes DE; Akhter S; Kulaylat MN; Islam A; Chadha KC
    Cancer; 2003 Dec; 98(12):2730-3. PubMed ID: 14669296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cord blood cells on interferonogenesis and effector cells of immune system.
    Lazarenko LM; Demchenko OM; Rachkova LT; Kryvokhats'ka LD; Olevins'ka ZM; Spivak MY
    Fiziol Zh (1994); 2008; 54(4):47-54. PubMed ID: 18756775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current approaches to diagnosis and management of ocular lesions in human immunodeficiency virus positive patients.
    Biswas J; Fogla R; Gopal L; Narayana KM; Banker AS; Kumarasamy N; Madhavan HN
    Indian J Ophthalmol; 2002 Jun; 50(2):83-96. PubMed ID: 12194584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.